Dr Eva Kubala Havrdova is Professor of Neurology at the First Faculty of Medicine, General University Hospital, Charles University in Prague, Czech Republic.
She obtained her medical degree at the same university in 1981 and went on to specialize in neurology and became Professor at Charles University in 2010. She is currently Director of the Center for Demyelinating Diseases at Charles University, Prague.
Dr Kubala Havrdová’s research interests include cytokine, immunoglobulin & T-cell research in multiple sclerosis, treatment of malignant MS. She created “freedom from disease activity” concept used now to compare efficacy of MS drugs. She has published more than 250 publications on multiple sclerosis including Neuroimmunology, Multiple Sclerosis, Handbook on MS for General Practitioners, Pharmacotherapy of MS, and several books for patients.
She organized ECTRIMS Congress in Prague in 2007, is a member of MSIF International Medical and Scientific Board, and member of the Czech Neurological Society Committee. She introduced disease modifying treatment in MS in Czech Republic and established a network of MS Centers covering all the country. She developed Standards of Diagnostics and Treatment of MS and NMO in Czech Republic.
Dr Eva Kubala Havrdova is Professor of Neurology at the First Faculty of Medicine, General University Hospital, Charles University in Prague, Czech Republic.
She obtained her medical degree at the same university in 1981 and went on to specialize in neurology and became Professor at Charles University in 2010. She is currently Director of the Center for Demyelinating Diseases at Charles University, Prague.
Dr Kubala Havrdová’s research interests include cytokine, immunoglobulin & T-cell research in multiple sclerosis, treatment of malignant MS. She created “freedom from disease activity” concept used now to compare efficacy of MS drugs. She has published more than 250 publications on multiple sclerosis including Neuroimmunology, Multiple Sclerosis, Handbook on MS for General Practitioners, Pharmacotherapy of MS, and several books for patients.
She organized ECTRIMS Congress in Prague in 2007, is a member of MSIF International Medical and Scientific Board, and member of the Czech Neurological Society Committee. She introduced disease modifying treatment in MS in Czech Republic and established a network of MS Centers covering all the country. She developed Standards of Diagnostics and Treatment of MS and NMO in Czech Republic.
